Skutecznosc preparatu Finadyne w profilaktyce i terapii zespolu MMA u loch

• Autorzy: Kotowski K , Szrom A. , Dus R.

Warianty tytułu

EN

Efficacy of Finadyne in the control and therapy of MMA syndrome in sows

• Języki publikacji: PL

Abstrakty

EN

The aim of the study was the evaluation of the preventive and therapeutic efficacy of Finadyne in the event of MMA risk in sows. The experiment was conducted in two farms of similar environmental conditions. The study included 42 sows aged 1-3 years and 469 piglets born to these females. The animals, randomly chosen in each farm, were divided into 2 groups, i.e. experimental and control ones. In farm A 9 sows, while in farm B 12 females were included per group. Each sow of the experimental group was injected intramuscularly with Finadyne at a dose of 2 ml/50 kg b.w. (2 mg of flunixin/kg b.w.), and, if necessary, the injection of the product was repeated after 24 hours. The females of the control group were not treated with medicines at all. In total, the MMA syndrome occurred in 5 sows (23.80%) in the experimental groups in both farms, while 7 sows in the control groups (33.33%) were affected. Number and body weight of piglets at birth date were very similar in the tested groups. However, subsequently during the newborn piglets. lives the yield expressed by daily gains were statistically significant (p ≤ 0.05) to the advantage of litters of the experimental sows. This is a measurable indicator of Finadyne action. In the group of the sows treated with Finadyne, the diarrhoea signs were found in 5 litters (23.80%), while in the control groups in 7 litters (33.33%). In the experimental groups, 11 piglets died up to 21 day of life, i.e. 4.70%, while in the control groups . 16 newborns (6.86%), i.e. 2.16% piglets more. It was also discovered that administration of the product to sows after farrowing had a positive influence on fertility, as well as an impact on mating efficacy and rejection rate. All in all, 95.20% of sows of the experimental groups were effectively inseminated, while 90.40% in controls.

Słowa kluczowe

PL

preparat Finadyne; trzoda chlewna; skutecznosc; profilaktyka; leczenie; syndrom MMA; choroby zwierzat; lochy

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2006
• Tom: 62
• Numer: 11
• Opis fizyczny: s.1252-1255,tab.,bibliogr.

Twórcy

autor

Kotowski K

• ul.Kombatantow 10, 63-600 Kepno

autor

Szrom A.

autor

Dus R.

Bibliografia

• 1.Anon.: Normy Żywienia Świñ. Omnitech Press, Warszawa 1993.
• 2.Bednarek D., Zdzisiñska B., Kondracki M., Rzeski W., Paduch R., Kandefer-Szerszeñ M.: A comparative study of the effects of meloxicam and flunixin meglumine (NSAIDs) as adjunctive therapy on interferon and tumor necrosis factor production in calves suffering from enzootic bronchopneumonia. Pol. J. Vet. Sci. 2003, 6, 109-115.
• 3.Bossow H., Bodiker R., Richter H.: Artificial infection of vagina for the prevention of Metritis, Mastitis and Colibacillosis. Proc. Congr. IPVS, Thailand 1994, s. 375.
• 4.Bostedt H., Maier G., Kerstin Herfen, Hospes R.: Klinische Erhebungen bei Sauen mit puerperaler Septikamie und Toxamie. Tierärztl. Prax. 1998, 26, 332-338.
• 5.Cerne F., Jerkovic I., Debeljak C.: Influence of Finadyne (R) on some clinical sings of MMA. Proc. Congr. IPVS, Ghent 1984, s. 290.
• 6.Danek J.: Wpływ endotoksyny i megluminianu fluniksyny na wskaŸniki krwi u koni. Medycyna Wet. 2005, 61, 1395-1399.
• 7.De Ruijter K., Verheijden J. H. M., Pijpers A., Berends J.: The patogenes of coliform mastitis in the sow. Proc. Congr. IPVS, Barcelona 1986, s. 95.
• 8.Elmore R. G., Martin C. E., Berg J. N.: Absorption of Escherichia coli endotoxin from the mammary glands and uteri of early postpartum sows and hilts. Theriogenology 1978, 10, 439-445.
• 9.Hirsch A. C., Philipp H., Kleemann R.: Investigation on the efficacy of meloxicam in sows with mastitis-metritis-agalactia syndrome. J. Vet. Pharmacol. Therap. 2003, 26, 355-360.
• 10.Hoppe R.: Toksemiczna bezmleczność macior. Życie Wet. 1970, 45, 261-262.
• 11. Janowski H.: Kolibakteriozy świñ w Polsce ze szczególnym uwzględnieniem badañ nad etiologią i patogenezą. Medycyna Wet. 1968, 24, 89-93.
• 12.Kotowski K.: Występowanie, straty oraz skuteczność profilaktyki nieswoistej i swoistej zespołu bezmleczności poporodowej u loch. Praca hab., ART, Olsztyn 1996.
• 13.Landoni M. F., Cunningham F. M., Lees P.: Comparative pharmacodynamics of flunixin, ketoprofen and tolfenamic acid in calves. Vet. Rec. 1995, 137, 428-431.
• 14.Landoni M. F., Cunningham F. M., Lees P.: Pharmacokinetics and pharmacodynamics of tolfenamic acid in calves. Res. Vet. Sci. 1996, 61, 26-32.
• 15.Lofstedt J. A., Ross R. F., Wagner W. C.: Depression of polymarphonuclear leukocyte function associated with experimentally induced Escherichia coli mastitis in sows. Am. J. Vet. Res. 1983, 44, 1224-1228.
• 16.Markoc A., Backstrom L., Lund L., Smith A. R.: Bacterial endotoxin in blood of dysgalactie sows in relation to microbial status of uterus, milk and intestine. J. Am. Vet. Med. Ass. 1983, 183, 786-789.
• 17.Nachreiner R. F., Ginther O. J.: Induction of agalactia by administration of endotoxin (Escherichia coli) in swine. Am. J. Vet. Res. 1974, 35, 619-622.
• 18.Olier N., Bertschinger H. U.: Prophylaxis of experimentally induced Coliform mastitis in the sow with enrofloxacin (Baytril). Proc. Congr. IPVS, Lausane 1990, s. 186.
• 19.Pedersen A., Krovacek K., Ekwall H.: Virulence factors in strains of Escherichia coli isolated from mastitis milk from agalactie sows. Proc. Congr. IPVS, Ghent 1984, s. 286.
• 20.Pejsak Z., Kopczewski A., Błaszczyk B., Sadoch L.: Profilaktyka swoista w ograniczaniu strat spowodowanych bezmlecznością poporodową loch. Życie Wet. 1990, 65, 69-71.
• 21.Rekiel A.: Bezmleczność poporodowa loch etiologia i profilaktyka. Medycyna Wet. 1999, 55, 440-444.
• 22.Rekiel A.: Wpływ poziomu żywienia w okresie zasuszania na zdrowotność gruczołu mlekowego loch. Medycyna Wet. 2002, 58, 40-44.
• 23.Smith B., Wagner W. C.: Suppresion of prolactin in pigs by Escherichia coli endotoxin. Science 1984, 224, 605-606.
• 24.Tarasiuk K., Pejsak Z.: Udział endotoksyny E. coli w etiologii bezmleczności poporodowej u loch. Medycyna Wet. 1986, 42, 323-327.
• 25.Tarasiuk K., Wasiñski B., Pejsak Z.: Skuteczność profilaktyki swoistej w ograniczaniu strat związanych z występowaniem zespołu MMA u loch. Magazyn Wet. 1994, 3, 8-12.
• 26.Truszczyñski M., Pejsak Z., Tarasiuk K.: Role of endotoxin, measured with the LAL test, in Coliform Mastitis of sows. Proc. Congr. IPVS, Rio de Janeiro 1988, s. 303.
• 27.Wegmann P., Bertschinger H. U., Jecklin H.: A field study on the prevalence of coliform mastitis (MMA) in Switzerland and the antimicrobial susceptibility of the coliform bacteria isolated from the milk. Proc. Congr. IPVS, Barcelona 1986.
• 28.Wojciechowski M.: Choroby zwyrodnieniowe stawów u psów. Cz. III. Rozpoznanie i leczenie. Życie Wet. 2005, 80, 707-714.